Technology
Health
Biotechnology

CohBar

$1.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (4.81%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CohBar and other stocks, options, ETFs, and crypto commission-free!

About

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. Read More The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.

Employees
12
Headquarters
Pasadena, California
Founded
2007
Market Cap
83.74M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
109.77K
High Today
$1.97
Low Today
$1.85
Open Price
$1.89
Volume
31.78K
52 Week High
$10.79
52 Week Low
$1.85

Collections

Technology
Health
Biotechnology
Research And Development
Therapy
Cancer Prevention
2017 IPO
US

News

Yahoo FinanceMay 8

Edited Transcript of COB.U.V earnings conference call or presentation 7-May-19 9:00pm GMT

Q1 2019 CohBar Inc Earnings Call MENLO PARK May 8, 2019 (Thomson StreetEvents) -- Edited Transcript of CohBar Inc earnings conference call or presentation Tuesday, May 7, 2019 at 9:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Jeffrey F. Biunno CohBar, Inc. - CFO, Treasurer & Secretary * Kenneth C. Cundy CohBar, Inc. - Ch...

27
NasdaqMay 7

CohBar Reports First Quarter 2019 Financial Results and Business Update

Company to host conference call and webcast today, May 7, at 5:00 p.m. EDT MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today reported its financial results for the first quarter ended March 31, 2019. "The clear highlight since our last quarterly update was our announcement last week that we will be resuming the clinical...

24
Yahoo FinanceMay 7

CohBar, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2019 / CohBar, Inc. (NASDAQ: CWBR) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-19B39276A55CC To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile. About Investor Network Investor ...

8

Earnings

-$0.11
-$0.10
-$0.08
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.